Aurobindo Pharma is currently trading at Rs. 583.80, up by 28.80 points or 5.19% from its previous closing of Rs. 555.00 on the BSE.
The scrip opened at Rs. 582.00 and has touched a high and low of Rs. 585.25 and Rs. 571.90 respectively. So far 107314 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 838.00 on 30-Apr-2019 and a 52 week low of Rs. 537.00 on 05-Aug-2019.
Last one week high and low of the scrip stood at Rs. 585.25 and Rs. 537.00 respectively. The current market cap of the company is Rs. 33983.11 crore.
The promoters holding in the company stood at 51.87%, while Institutions and Non-Institutions held 35.23% and 12.90% respectively.
The company has reported a rise of 46.81% in its net profit at Rs 330.50 crore for first quarter ended June 30, 2019 as compared to Rs 225.12 crore for the same quarter in the previous year. Total income of the company increased by 21.37% at Rs 3,108.97 crore for Q1FY20 as compared Rs 2,561.64 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 39.53% in its net profit at Rs 635.68 crore for the quarter under review as compared to Rs 455.59 crore for the same quarter in the previous year. Total income of the company increased by 27.16% at Rs 5,460.38 crore for Q1FY20 as compared Rs 4294.00 crore for the corresponding quarter previous year.